0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.14%
Negative revenue growth while 0819.HK stands at 36.79%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.81%
Negative gross profit growth while 0819.HK is at 43.87%. Joel Greenblatt would examine cost competitiveness or demand decline.
0.61%
EBIT growth below 50% of 0819.HK's 70.09%. Michael Burry would suspect deeper competitive or cost structure issues.
0.61%
Operating income growth under 50% of 0819.HK's 70.09%. Michael Burry would be concerned about deeper cost or sales issues.
27.53%
Net income growth under 50% of 0819.HK's 68.35%. Michael Burry would suspect the firm is falling well behind a key competitor.
-44.39%
Negative EPS growth while 0819.HK is at 68.42%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
3.34%
Diluted EPS growth under 50% of 0819.HK's 68.42%. Michael Burry would worry about an eroding competitive position or excessive dilution.
129.62%
Share count expansion well above 0819.HK's 1.31%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.43%
Diluted share count expanding well above 0819.HK's 0.44%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
114.48%
OCF growth at 75-90% of 0819.HK's 145.29%. Bill Ackman would demand better working capital management or cost discipline.
79.98%
FCF growth under 50% of 0819.HK's 304.40%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
31.83%
10Y revenue/share CAGR under 50% of 0819.HK's 1118.52%. Michael Burry would suspect a lasting competitive disadvantage.
-55.08%
Negative 5Y CAGR while 0819.HK stands at 196.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-50.53%
Negative 3Y CAGR while 0819.HK stands at 99.27%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
305.97%
10Y OCF/share CAGR under 50% of 0819.HK's 1315.74%. Michael Burry would worry about a persistent underperformance in cash creation.
-9.31%
Negative 5Y OCF/share CAGR while 0819.HK is at 1815.92%. Joel Greenblatt would question the firm’s operational model or cost structure.
-66.91%
Negative 3Y OCF/share CAGR while 0819.HK stands at 27.57%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-34.65%
Negative 10Y net income/share CAGR while 0819.HK is at 458.19%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.96%
Negative 5Y net income/share CAGR while 0819.HK is 96.34%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
110.85%
Below 50% of 0819.HK's 301.27%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
-3.30%
Negative 5Y equity/share growth while 0819.HK is at 50.86%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-32.09%
Negative 3Y equity/share growth while 0819.HK is at 74.66%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-55.41%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
83.57%
Inventory growth well above 0819.HK's 11.91%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-17.48%
Negative asset growth while 0819.HK invests at 4.84%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-51.38%
We have a declining book value while 0819.HK shows 15.70%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.12%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-18.82%
Our R&D shrinks while 0819.HK invests at 40.20%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-17.25%
We cut SG&A while 0819.HK invests at 42.20%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.